Michael D. Bookman - 08 Feb 2024 Form 4 Insider Report for Immuneering Corp (IMRX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMRX	Stock Option	Award	$0	+93,000		$0.000000	93,000	08 Feb 2024	Class A Common Stock	93,000	$6.09	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028.